AMANDA PALMER: Open Payments
NPI 1467018895 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 49 payments from 14 companies in 2025. Trend: 2023 $633 · 2024 $1,211 · 2025 $1,000
Food & beverage: $928Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $273 |
| UCB, Inc. | 4 | $163 |
| Galderma Laboratories, L.P. | 16 | $148 |
| ABBVIE INC. | 3 | $68 |
| GENZYME CORPORATION | 3 | $59 |
| Organogenesis Inc. | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Organon LLC | 3 | $46 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, DUPIXENT, SKYRIZI, ILUMYA, AKLIEF, VIA MATRIX.
Industry payments across TX — which companies pay providers there.
